Skip to main content
. 2018 Mar 28;2(7):745–753. doi: 10.1182/bloodadvances.2018017731

Table 2.

Clinical outcomes

Outcome Value
Patients receiving FMT, n 13
Median time from allo-HCT to FMT (range), d 27 (19-45)
Median follow-up (range), mo 15 (13-20)
C difficile colitis, n 1
Bacteremia, n 1
Grade 3-4 acute GVHD, n 2
Deaths, n 2